Celon Pharma S.A. (WSE:CLN)

Poland · Delayed Price · Currency is PLN

21.15

+0.05 (0.24%)

May 27, 2026, 1:33 PM CET

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Generic medicines	176.62M	164.39M	161.92M	169.56M	135.48M
Generic medicines Growth	7.44%	1.53%	-4.51%	25.15%	-
Innovative	27.44M	49.53M	31.97M	26.53M	21.87M
Innovative Growth	-44.61%	54.91%	20.52%	21.28%	-
Total	204.05M	213.92M	193.89M	196.09M	157.35M
Total Growth	-4.61%	10.33%	-1.12%	24.62%	53.90%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Poland	164.64M	156.94M	135.17M	119.14M	115.98M
Poland Growth	4.91%	16.10%	13.46%	2.72%	-
Export	42.54M	59.62M	59.42M	79.97M	44.01M
Export Growth	-28.65%	0.35%	-25.70%	81.71%	-
Total	207.19M	216.57M	194.59M	199.11M	159.99M
Total Growth	-4.33%	11.29%	-2.27%	24.45%	-

Source: S&P Global Market Intelligence.